Benitec Biopharma (Contra CUSIP)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BNIKF and buy or sell other stocks, ETFs, and their options commission-free!About BNIKF
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases. Their transformational technology, ddRNAi, targets and ‘turns off’ specific genes related to disease, providing lasting treatment and potentially cure with a single dose.
CEOJerel A. Banks, MD, PhD
CEOJerel A. Banks, MD, PhD
Employees—
Employees—
HeadquartersBalmain, New South Wales (NSW)
HeadquartersBalmain, New South Wales (NSW)
Founded1997
Founded1997
Employees—
Employees—
BNIKF Key Statistics
Market cap19.20M
Market cap19.20M
Price-Earnings ratio-0.93
Price-Earnings ratio-0.93
Dividend yield—
Dividend yield—
Average volume30.27K
Average volume30.27K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.49
52 Week high$10.49
52 Week low$1.90
52 Week low$1.90
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.